DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...

Sight Sciences’ management is scheduled to present on Tuesday, April 8, 2025, at 12:45 pm PT / 3:45 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

A real-world analysis finds minimally invasive canaloplasty for glaucoma lowers intraocular pressure by 20% or more in half ...

The number of people with glaucoma worldwide will increase to 111.8 million in 2040, disproportionately affecting people residing in Asia (1). The gradual increase by 2040 shows the importance of ...

Press Release Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Results expected in May 2025 Last ...

The following is a summary of “Adjuvant Brachytherapy Using Iodine-125 Plaques for Conjunctival Melanoma with Scleral ...

Fintel reports that on March 18, 2025, RBC Capital initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform ...

Take Gucci prescription glasses, which feature classic styles like the GG1340O and GG0343O, which are made of lightweight, ...

A combination of low blood pressure and high intraocular pressure can predict RNFL thinning in moderate-to-severe glaucoma.

Glaucoma is the leading cause of blindness in Qatar, and the most at risk groups are individuals over the age of 40 and those ...